Medical Devices

A new study on couples' supplements shows impressive well-being gains, but a closer look at the methodology reveals a gap between marketing and hard science.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

A California small business beat 11 rivals for a landmark FBI armor contract. The Nguyen Report dissects the strategy and tech setting a new industry standard.

Shanti Recovery & Wellness gains DHCS accreditation, launching a virtual IOP that combines clinical therapy with holistic practices for California adults.

Pluri is moving its advanced cell-expansion tech from the lab to the lucrative U.S. aesthetics market. Is this a savvy commercial pivot or a risky gamble?

Aethlon Medical's upcoming financial report is more than a balance sheet; it's a test of viability for its revolutionary Hemopurifier blood filter.

A new manufacturing deal sees Bluejay Diagnostics bet on U.S. resilience. It's a strategic retreat from global risk for a firm facing a long regulatory road.

A breakthrough in cardiac fibrosis treatment reveals more than a new drug; it signals a systemic shift. How AI and human 'organoids' are making animal models obsolete.

A pivotal trial completes enrollment at a record pace while the AMA lays the groundwork for billing. ShiraTronics is rewriting the medtech playbook.

A Japanese firm has achieved a breakthrough in manufacturing ultra-smooth capillary tubes, a tiny component set to unlock major advances in medicine and tech.

With a seasoned drug developer at the helm, preclinical biotech FundaMental Pharma signals a major push to bring its novel TRD therapy through the clinical gauntlet.

China's oldest watchmaker is democratizing high horology on Kickstarter. We break down the tech, the value, and the strategy behind this bold global play.

A pioneer in professional chemical peels, PCA SKIN is strategically expanding its legacy into the booming at-home market. Their new Triple Exfoliation Peel Pads exemplify operational innovation, offering clinic-grade results and barrier support for the discerning consumer.

Revance unites its top acne treatment, PanOxyl, and microneedling device, SkinPen, in a strategic play to capture the holistic skincare market.

With $12M in new funding, Veritas Aortic Solutions aims to replace high-risk open-heart surgery with a groundbreaking transcatheter device for the aorta.

A new study on runners reveals how vagus nerve stimulation improves recovery and sleep, pioneering a 'Stress Fitness' approach for athletes.

Facing delisting, biotech firm Cuprina Holdings executes a reverse split and appeals to Nasdaq. Will the high-stakes gamble pay off for the company?

SurGenTec's FDA clearance for its ION-C™ system, now compatible with Medtronic navigation, signals a new era of precision in cervical spine surgery.

As a Chinese firm brings its water-saving hydrogels to Australia, it reveals a deeper shift in agritech: from selling products to deploying integrated, climate-resilient solutions.

Gene Solutions' SPOT-MAS 10 test gains FDA Breakthrough Designation, accelerating its path to the U.S. market and heralding a new era in early cancer detection.